| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sodium:bicarbonate symporter activity | 1.53e-06 | 6 | 86 | 3 | GO:0008510 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 1.65e-05 | 12 | 86 | 3 | GO:0030023 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.68e-05 | 188 | 86 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | oxysterol 7-alpha-hydroxylase activity | 1.83e-05 | 2 | 86 | 2 | GO:0008396 | |
| GeneOntologyMolecularFunction | monoatomic cation:bicarbonate symporter activity | 2.14e-05 | 13 | 86 | 3 | GO:0140410 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 2.61e-05 | 81 | 86 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 2.71e-05 | 14 | 86 | 3 | GO:0097493 | |
| GeneOntologyMolecularFunction | 24-hydroxycholesterol 7alpha-hydroxylase activity | 5.48e-05 | 3 | 86 | 2 | GO:0033782 | |
| GeneOntologyMolecularFunction | sodium,bicarbonate:chloride antiporter activity | 5.48e-05 | 3 | 86 | 2 | GO:0140892 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 1.64e-04 | 119 | 86 | 5 | GO:0015294 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 1.70e-04 | 120 | 86 | 5 | GO:0004222 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 3.50e-04 | 32 | 86 | 3 | GO:0015106 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 3.50e-04 | 32 | 86 | 3 | GO:0005452 | |
| GeneOntologyMolecularFunction | symporter activity | 4.78e-04 | 150 | 86 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | transition metal ion binding | ZNF8 CPSF4 SLC4A8 BRCA1 PRICKLE1 POLE CIAPIN1 ZFAND6 XDH CYP7B1 ZFAND5 ADAM8 CYP39A1 SORD | 5.28e-04 | 1189 | 86 | 14 | GO:0046914 |
| GeneOntologyMolecularFunction | growth factor binding | 5.71e-04 | 156 | 86 | 5 | GO:0019838 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 8.65e-04 | 171 | 86 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 1.39e-03 | 13 | 86 | 2 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 1.39e-03 | 13 | 86 | 2 | GO:0140829 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 1.73e-03 | 200 | 86 | 5 | GO:0008237 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 1.76e-03 | 296 | 86 | 6 | GO:0015291 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF597 ZNF8 ZNF133 ZNF536 GTF2IRD2B ZNF547 ZNF268 ZNF549 ZNF423 ZNF256 GTF2IRD2 ZNF518B ZNF625 ZNF354B | 2.72e-03 | 1412 | 86 | 14 | GO:0000981 |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 2.99e-03 | 19 | 86 | 2 | GO:0005520 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 3.92e-03 | 465 | 86 | 7 | GO:0046873 | |
| GeneOntologyMolecularFunction | iron-sulfur cluster binding | 4.65e-03 | 78 | 86 | 3 | GO:0051536 | |
| GeneOntologyMolecularFunction | zinc ion binding | ZNF8 CPSF4 SLC4A8 BRCA1 PRICKLE1 POLE ZFAND6 ZFAND5 ADAM8 SORD | 4.90e-03 | 891 | 86 | 10 | GO:0008270 |
| GeneOntologyMolecularFunction | metal cluster binding | 5.53e-03 | 83 | 86 | 3 | GO:0051540 | |
| GeneOntologyBiologicalProcess | cell-substrate junction organization | 8.61e-06 | 115 | 86 | 6 | GO:0150115 | |
| GeneOntologyBiologicalProcess | retina vasculature morphogenesis in camera-type eye | 1.13e-05 | 11 | 86 | 3 | GO:0061299 | |
| GeneOntologyBiologicalProcess | endothelial tip cell fate specification | 5.14e-05 | 3 | 86 | 2 | GO:0097102 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 5.29e-05 | 410 | 86 | 9 | GO:0031589 | |
| GeneOntologyBiologicalProcess | cell-substrate junction assembly | 8.92e-05 | 108 | 86 | 5 | GO:0007044 | |
| GeneOntologyBiologicalProcess | blood vessel endothelial cell fate specification | 1.03e-04 | 4 | 86 | 2 | GO:0097101 | |
| GeneOntologyBiologicalProcess | blood vessel endothelial cell fate commitment | 1.03e-04 | 4 | 86 | 2 | GO:0060846 | |
| GeneOntologyBiologicalProcess | cell junction assembly | 1.27e-04 | 569 | 86 | 10 | GO:0034329 | |
| GeneOntologyBiologicalProcess | negative regulation of protein localization to microtubule | 1.70e-04 | 5 | 86 | 2 | GO:1902817 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to microtubule | 1.70e-04 | 5 | 86 | 2 | GO:1902816 | |
| GeneOntologyBiologicalProcess | endothelial cell fate specification | 1.70e-04 | 5 | 86 | 2 | GO:0060847 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 1.77e-04 | 377 | 86 | 8 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 1.81e-04 | 378 | 86 | 8 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 1.84e-04 | 379 | 86 | 8 | GO:0045229 | |
| GeneOntologyBiologicalProcess | cell junction organization | COL4A1 TRIP6 PRICKLE1 FZD5 C1QL3 LAMC1 BSN ADGRL2 AJUBA UNC13A ABHD17C EPHA3 NRP1 | 1.90e-04 | 974 | 86 | 13 | GO:0034330 |
| GeneOntologyBiologicalProcess | retina vasculature development in camera-type eye | 2.62e-04 | 30 | 86 | 3 | GO:0061298 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside metabolic process | 3.18e-04 | 32 | 86 | 3 | GO:0046128 | |
| GeneOntologyBiologicalProcess | renal system vasculature morphogenesis | 3.56e-04 | 7 | 86 | 2 | GO:0061438 | |
| GeneOntologyBiologicalProcess | kidney vasculature morphogenesis | 3.56e-04 | 7 | 86 | 2 | GO:0061439 | |
| GeneOntologyBiologicalProcess | dAMP catabolic process | 3.56e-04 | 7 | 86 | 2 | GO:0046059 | |
| GeneOntologyCellularComponent | extracellular matrix | COL4A1 MXRA5 FBLN2 FBN2 IGFBP7 CLU TFPI2 ADAMTS16 ADAMTS18 LAMC1 LAMC3 CCN2 | 1.51e-05 | 656 | 86 | 12 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A1 MXRA5 FBLN2 FBN2 IGFBP7 CLU TFPI2 ADAMTS16 ADAMTS18 LAMC1 LAMC3 CCN2 | 1.56e-05 | 658 | 86 | 12 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 3.29e-04 | 530 | 86 | 9 | GO:0062023 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 3.52e-04 | 320 | 86 | 7 | GO:0016323 | |
| GeneOntologyCellularComponent | basal plasma membrane | 6.43e-04 | 354 | 86 | 7 | GO:0009925 | |
| GeneOntologyCellularComponent | basal part of cell | 9.44e-04 | 378 | 86 | 7 | GO:0045178 | |
| Domain | Growth_fac_rcpt_ | NELL2 FBLN2 FBN2 SCUBE2 IGFBP7 LAMC1 LAMC3 CCN2 DLL1 NOTCH3 EPHA3 | 1.38e-10 | 156 | 86 | 11 | IPR009030 |
| Domain | EGF_2 | 3.83e-07 | 265 | 86 | 10 | PS01186 | |
| Domain | EGF | 1.34e-06 | 235 | 86 | 9 | SM00181 | |
| Domain | EGF-like_dom | 2.17e-06 | 249 | 86 | 9 | IPR000742 | |
| Domain | EGF_1 | 2.64e-06 | 255 | 86 | 9 | PS00022 | |
| Domain | Znf_C2H2-like | ZNF597 ZNF8 ZNF133 ZNF821 ZNF536 GTF2IRD2B ZNF547 ZNF268 ZNF549 ZNF423 ZNF256 GTF2IRD2 ZNF518B ZNF625 ZNF354B | 3.15e-06 | 796 | 86 | 15 | IPR015880 |
| Domain | EGF-like_CS | 3.19e-06 | 261 | 86 | 9 | IPR013032 | |
| Domain | ANION_EXCHANGER_2 | 3.26e-06 | 7 | 86 | 3 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 3.26e-06 | 7 | 86 | 3 | PS00219 | |
| Domain | ZnF_C2H2 | ZNF597 ZNF8 ZNF133 ZNF821 ZNF536 GTF2IRD2B ZNF547 ZNF268 ZNF549 ZNF423 ZNF256 GTF2IRD2 ZNF518B ZNF625 ZNF354B | 3.78e-06 | 808 | 86 | 15 | SM00355 |
| Domain | EGF_Ca-bd_CS | 5.65e-06 | 97 | 86 | 6 | IPR018097 | |
| Domain | EGF_CA | 6.35e-06 | 99 | 86 | 6 | PS01187 | |
| Domain | ASX_HYDROXYL | 6.74e-06 | 100 | 86 | 6 | PS00010 | |
| Domain | Band3_cytoplasmic_dom | 7.76e-06 | 9 | 86 | 3 | IPR013769 | |
| Domain | Band_3_cyto | 7.76e-06 | 9 | 86 | 3 | PF07565 | |
| Domain | - | 7.76e-06 | 9 | 86 | 3 | 3.40.1100.10 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 9.43e-06 | 106 | 86 | 6 | IPR000152 | |
| Domain | HCO3_cotransp | 1.11e-05 | 10 | 86 | 3 | PF00955 | |
| Domain | HCO3_transpt_C | 1.11e-05 | 10 | 86 | 3 | IPR011531 | |
| Domain | PTrfase/Anion_transptr | 1.11e-05 | 10 | 86 | 3 | IPR016152 | |
| Domain | HCO3_transpt_euk | 1.11e-05 | 10 | 86 | 3 | IPR003020 | |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF597 ZNF8 ZNF133 ZNF821 ZNF536 ZNF547 ZNF268 ZNF549 ZNF423 ZNF256 ZNF518B ZNF625 ZNF354B | 1.65e-05 | 694 | 86 | 13 | IPR013087 |
| Domain | EGF_CA | 2.11e-05 | 122 | 86 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.31e-05 | 124 | 86 | 6 | IPR001881 | |
| Domain | EGF_CA | 4.78e-05 | 86 | 86 | 5 | PF07645 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF597 ZNF8 ZNF133 ZNF821 ZNF536 ZNF547 ZNF268 ZNF549 ZNF423 ZNF256 ZNF518B ZNF625 ZNF354B | 5.18e-05 | 775 | 86 | 13 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF597 ZNF8 ZNF133 ZNF821 ZNF536 ZNF547 ZNF268 ZNF549 ZNF423 ZNF256 ZNF518B ZNF625 ZNF354B | 5.32e-05 | 777 | 86 | 13 | PS00028 |
| Domain | - | ZNF597 ZNF8 ZNF133 ZNF821 ZNF536 ZNF547 ZNF268 ZNF549 ZNF423 ZNF256 ZNF625 ZNF354B | 6.30e-05 | 679 | 86 | 12 | 3.30.160.60 |
| Domain | Znf_C2H2 | ZNF597 ZNF8 ZNF133 ZNF821 ZNF536 ZNF547 ZNF268 ZNF549 ZNF423 ZNF256 ZNF518B ZNF625 ZNF354B | 7.62e-05 | 805 | 86 | 13 | IPR007087 |
| Domain | ZINC_PROTEASE | 8.93e-05 | 98 | 86 | 5 | PS00142 | |
| Domain | zf-C2H2_6 | 9.93e-05 | 314 | 86 | 8 | PF13912 | |
| Domain | EGF_3 | 1.05e-04 | 235 | 86 | 7 | PS50026 | |
| Domain | - | 1.25e-04 | 4 | 86 | 2 | 3.90.1460.10 | |
| Domain | GTF2I | 1.25e-04 | 4 | 86 | 2 | PS51139 | |
| Domain | GTF2I | 1.25e-04 | 4 | 86 | 2 | PF02946 | |
| Domain | GTF2I | 1.25e-04 | 4 | 86 | 2 | IPR004212 | |
| Domain | Cyt_P450_CYP7A1-type | 2.08e-04 | 5 | 86 | 2 | IPR024204 | |
| Domain | Anion_exchange | 2.08e-04 | 5 | 86 | 2 | IPR001717 | |
| Domain | Na/HCO3_transpt | 2.08e-04 | 5 | 86 | 2 | IPR003024 | |
| Domain | cEGF | 2.27e-04 | 26 | 86 | 3 | IPR026823 | |
| Domain | cEGF | 2.27e-04 | 26 | 86 | 3 | PF12662 | |
| Domain | KRAB | 2.44e-04 | 358 | 86 | 8 | PS50805 | |
| Domain | KRAB | 2.44e-04 | 358 | 86 | 8 | PF01352 | |
| Domain | hEGF | 2.84e-04 | 28 | 86 | 3 | PF12661 | |
| Domain | LIM | 2.88e-04 | 69 | 86 | 4 | PF00412 | |
| Domain | KRAB | 2.99e-04 | 369 | 86 | 8 | SM00349 | |
| Domain | KRAB | 3.04e-04 | 370 | 86 | 8 | IPR001909 | |
| Domain | - | 3.05e-04 | 70 | 86 | 4 | 2.10.110.10 | |
| Domain | Znf_LIM | 3.22e-04 | 71 | 86 | 4 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 3.22e-04 | 71 | 86 | 4 | PS00478 | |
| Domain | LIM_DOMAIN_2 | 3.22e-04 | 71 | 86 | 4 | PS50023 | |
| Domain | LIM | 3.22e-04 | 71 | 86 | 4 | SM00132 | |
| Domain | zf-C2H2 | ZNF597 ZNF8 ZNF133 ZNF536 ZNF547 ZNF268 ZNF549 ZNF423 ZNF256 ZNF625 ZNF354B | 3.30e-04 | 693 | 86 | 11 | PF00096 |
| Domain | - | 3.58e-04 | 73 | 86 | 4 | 2.60.120.260 | |
| Domain | Znf_A20 | 4.34e-04 | 7 | 86 | 2 | IPR002653 | |
| Domain | ZF_A20 | 4.34e-04 | 7 | 86 | 2 | PS51036 | |
| Domain | zf-A20 | 4.34e-04 | 7 | 86 | 2 | PF01754 | |
| Domain | ZnF_A20 | 4.34e-04 | 7 | 86 | 2 | SM00259 | |
| Domain | MetalloPept_cat_dom | 5.32e-04 | 81 | 86 | 4 | IPR024079 | |
| Domain | - | 5.32e-04 | 81 | 86 | 4 | 3.40.390.10 | |
| Domain | - | 5.76e-04 | 8 | 86 | 2 | 4.10.1110.10 | |
| Domain | zf-AN1 | 5.76e-04 | 8 | 86 | 2 | PF01428 | |
| Domain | ZF_AN1 | 5.76e-04 | 8 | 86 | 2 | PS51039 | |
| Domain | LAMININ_IVA | 5.76e-04 | 8 | 86 | 2 | PS51115 | |
| Domain | Laminin_B | 5.76e-04 | 8 | 86 | 2 | PF00052 | |
| Domain | LamB | 5.76e-04 | 8 | 86 | 2 | SM00281 | |
| Domain | Znf_AN1 | 5.76e-04 | 8 | 86 | 2 | IPR000058 | |
| Domain | ZnF_AN1 | 5.76e-04 | 8 | 86 | 2 | SM00154 | |
| Domain | Laminin_IV | 5.76e-04 | 8 | 86 | 2 | IPR000034 | |
| Domain | Peptidase_M12B_N | 7.64e-04 | 39 | 86 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 7.64e-04 | 39 | 86 | 3 | PF01562 | |
| Domain | DISINTEGRIN_1 | 8.23e-04 | 40 | 86 | 3 | PS00427 | |
| Domain | Reprolysin | 8.23e-04 | 40 | 86 | 3 | PF01421 | |
| Domain | ADAM_MEPRO | 8.23e-04 | 40 | 86 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 8.23e-04 | 40 | 86 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 8.23e-04 | 40 | 86 | 3 | IPR001590 | |
| Domain | Disintegrin_dom | 8.85e-04 | 41 | 86 | 3 | IPR001762 | |
| Domain | Cyt_P450_E_grp-IV | 9.21e-04 | 10 | 86 | 2 | IPR002403 | |
| Domain | Galactose-bd-like | 9.32e-04 | 94 | 86 | 4 | IPR008979 | |
| Domain | Ephrin_rec_like | 1.12e-03 | 11 | 86 | 2 | PF07699 | |
| Domain | PLAC | 1.84e-03 | 14 | 86 | 2 | PF08686 | |
| Domain | Methyltransf_11 | 2.41e-03 | 16 | 86 | 2 | PF08241 | |
| Domain | Laminin_N | 2.41e-03 | 16 | 86 | 2 | IPR008211 | |
| Domain | LAMININ_NTER | 2.41e-03 | 16 | 86 | 2 | PS51117 | |
| Domain | Laminin_N | 2.41e-03 | 16 | 86 | 2 | PF00055 | |
| Domain | Methyltransf_11 | 2.41e-03 | 16 | 86 | 2 | IPR013216 | |
| Domain | LamNT | 2.41e-03 | 16 | 86 | 2 | SM00136 | |
| Domain | GPCR_2-like | 2.67e-03 | 60 | 86 | 3 | IPR017981 | |
| Domain | EGF_extracell | 2.67e-03 | 60 | 86 | 3 | IPR013111 | |
| Domain | EGF_2 | 2.67e-03 | 60 | 86 | 3 | PF07974 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 2.80e-03 | 61 | 86 | 3 | PS50261 | |
| Domain | IB | 3.06e-03 | 18 | 86 | 2 | SM00121 | |
| Domain | TSP_1 | 3.07e-03 | 63 | 86 | 3 | PF00090 | |
| Domain | TSP1 | 3.35e-03 | 65 | 86 | 3 | SM00209 | |
| Domain | TSP1_rpt | 3.35e-03 | 65 | 86 | 3 | IPR000884 | |
| Domain | TSP1 | 3.35e-03 | 65 | 86 | 3 | PS50092 | |
| Domain | PLAC | 3.41e-03 | 19 | 86 | 2 | PS50900 | |
| Domain | PLAC | 3.41e-03 | 19 | 86 | 2 | IPR010909 | |
| Domain | IGFBP-like | 3.77e-03 | 20 | 86 | 2 | IPR000867 | |
| Domain | IGFBP | 3.77e-03 | 20 | 86 | 2 | PF00219 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 1.37e-05 | 10 | 70 | 3 | M27335 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 1.37e-05 | 10 | 70 | 3 | MM15073 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 6.70e-05 | 140 | 70 | 6 | M587 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF597 PRMT6 ZNF133 CPSF4 ZNF547 BRCA1 ZNF268 ZNF549 PSMA3 AGRP ZNF256 CCN2 ZNF625 CR1 DLL1 ZNF354B CCNK NOTCH3 | 1.07e-04 | 1387 | 70 | 18 | M734 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.15e-04 | 300 | 70 | 8 | M610 | |
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 5.19e-09 | 26 | 86 | 5 | 34189436 | |
| Pubmed | Adamts18 Deficiency Causes Spontaneous SMG Fibrogenesis in Adult Mice. | 3.37e-08 | 37 | 86 | 5 | 34323105 | |
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 1.04e-07 | 18 | 86 | 4 | 39040056 | |
| Pubmed | 1.45e-07 | 5 | 86 | 3 | 23500099 | ||
| Pubmed | 1.60e-07 | 50 | 86 | 5 | 23658023 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | COL4A1 NELL2 CPSF4 FBN2 IGFBP7 CLU TFPI2 CIAPIN1 LAMC1 LAMC3 CCN2 POMT1 SLC29A1 NOTCH3 NRP1 | 2.38e-07 | 1201 | 86 | 15 | 35696571 |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 2.44e-06 | 86 | 86 | 5 | 28327460 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 4.43e-06 | 97 | 86 | 5 | 27559042 | |
| Pubmed | K+-Driven Cl-/HCO3- Exchange Mediated by Slc4a8 and Slc4a10. | 6.04e-06 | 2 | 86 | 2 | 38674160 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 21235539 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 23643458 | ||
| Pubmed | Expression cloning of an oxysterol 7alpha-hydroxylase selective for 24-hydroxycholesterol. | 6.04e-06 | 2 | 86 | 2 | 10748047 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 23492684 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 32183562 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 17928512 | ||
| Pubmed | Evaluation of ADAMTS12, ADAMTS16, ADAMTS18 and IL-33 serum levels in pre-eclampsia. | 6.04e-06 | 2 | 86 | 2 | 26382559 | |
| Pubmed | Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome. | 6.04e-06 | 2 | 86 | 2 | 15388857 | |
| Pubmed | Laminin γ-1 and collagen α-1 (VI) chain are galactose-α-1,3-galactose-bound allergens in beef. | 6.04e-06 | 2 | 86 | 2 | 24180678 | |
| Pubmed | 6.24e-06 | 48 | 86 | 4 | 35247391 | ||
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 6.50e-06 | 15 | 86 | 3 | 15895400 | |
| Pubmed | 7.99e-06 | 16 | 86 | 3 | 30579834 | ||
| Pubmed | 1.16e-05 | 18 | 86 | 3 | 18093989 | ||
| Pubmed | An exploratory study on CLU, CR1 and PICALM and Parkinson disease. | 1.81e-05 | 3 | 86 | 2 | 21912625 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 20739100 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 22015308 | ||
| Pubmed | Regulation of the human NBC3 Na+/HCO3- cotransporter by carbonic anhydrase II and PKA. | 1.81e-05 | 3 | 86 | 2 | 14736710 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 8923452 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 23650005 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 18697739 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 21300948 | ||
| Pubmed | Replication of CLU, CR1, and PICALM associations with alzheimer disease. | 1.81e-05 | 3 | 86 | 2 | 20554627 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 22952074 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 28968398 | ||
| Pubmed | The Impact of Complement Genes on the Risk of Late-Onset Alzheimer's Disease. | 1.81e-05 | 3 | 86 | 2 | 33804666 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 32991610 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 12482954 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 15100712 | ||
| Pubmed | Implication of common and disease specific variants in CLU, CR1, and PICALM. | 1.81e-05 | 3 | 86 | 2 | 22402018 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 30578652 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 12444018 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 8153091 | ||
| Pubmed | 2.00e-05 | 608 | 86 | 9 | 16713569 | ||
| Pubmed | 3.22e-05 | 146 | 86 | 5 | 27068509 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 3.61e-05 | 248 | 86 | 6 | 24006456 | |
| Pubmed | Binding of netrin-4 to laminin short arms regulates basement membrane assembly. | 3.61e-05 | 4 | 86 | 2 | 17588941 | |
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 14592810 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 23229069 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 22899722 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 12403779 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 21347408 | ||
| Pubmed | Molecular expression of SLC4-derived Na+-dependent anion transporters in selected human tissues. | 3.61e-05 | 4 | 86 | 2 | 17715183 | |
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 20697030 | ||
| Pubmed | Analysis of HeyL expression in wild-type and Notch pathway mutant mouse embryos. | 3.61e-05 | 4 | 86 | 2 | 11044625 | |
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 27619726 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 16507336 | ||
| Pubmed | Updated Meta-Analysis of BIN1, CR1, MS4A6A, CLU, and ABCA7 Variants in Alzheimer's Disease. | 3.61e-05 | 4 | 86 | 2 | 29504051 | |
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 17823943 | ||
| Pubmed | Whole-exome sequencing of Finnish patients with vascular cognitive impairment. | 3.61e-05 | 4 | 86 | 2 | 33268848 | |
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 21328569 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 19506372 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 11827796 | ||
| Pubmed | 3.64e-05 | 26 | 86 | 3 | 24742657 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 4.54e-05 | 79 | 86 | 4 | 18757743 | |
| Pubmed | ADAMTS18 Deficiency Leads to Pulmonary Hypoplasia and Bronchial Microfibril Accumulation. | 5.65e-05 | 30 | 86 | 3 | 32882513 | |
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 19734903 | ||
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 20674675 | ||
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 20554499 | ||
| Pubmed | Expression patterns of Notch receptors and their ligands Jagged and Delta in human placenta. | 6.01e-05 | 5 | 86 | 2 | 21726900 | |
| Pubmed | Physical interaction of Delta1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors. | 6.01e-05 | 5 | 86 | 2 | 11006133 | |
| Pubmed | Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory. | 6.01e-05 | 5 | 86 | 2 | 22539578 | |
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 21602525 | ||
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 12243745 | ||
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 8359228 | ||
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 7516699 | ||
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 7851641 | ||
| Pubmed | 7.03e-05 | 172 | 86 | 5 | 20628624 | ||
| Pubmed | 7.63e-05 | 175 | 86 | 5 | 28071719 | ||
| Pubmed | The transcription factor RBP-J is essential for retinal cell differentiation and lamination. | 8.26e-05 | 34 | 86 | 3 | 20017954 | |
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 19812333 | ||
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 9882480 | ||
| Pubmed | Methylation of CLDN6, FBN2, RBP1, RBP4, TFPI2, and TMEFF2 in esophageal squamous cell carcinoma. | 9.01e-05 | 6 | 86 | 2 | 19288010 | |
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 31787876 | ||
| Pubmed | Early Hearing Loss upon Disruption of Slc4a10 in C57BL/6 Mice. | 9.01e-05 | 6 | 86 | 2 | 31001720 | |
| Pubmed | Expression of Deltex1 during mouse embryogenesis: comparison with Notch1, 2 and 3 expression. | 9.01e-05 | 6 | 86 | 2 | 11731257 | |
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 14734538 | ||
| Pubmed | Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura. | 9.01e-05 | 6 | 86 | 2 | 19603167 | |
| Pubmed | Nidogen-2: a new basement membrane protein with diverse binding properties. | 9.01e-05 | 6 | 86 | 2 | 9733643 | |
| Pubmed | Notch signaling regulates smooth muscle differentiation of epicardium-derived cells. | 9.02e-05 | 35 | 86 | 3 | 21252157 | |
| Pubmed | 1.16e-04 | 38 | 86 | 3 | 31597102 | ||
| Pubmed | 1.26e-04 | 7 | 86 | 2 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 1.26e-04 | 7 | 86 | 2 | 12846471 | |
| Pubmed | Differentiation of CD11c+ CX3CR1+ cells in the small intestine requires Notch signaling. | 1.26e-04 | 7 | 86 | 2 | 24711412 | |
| Pubmed | 1.26e-04 | 7 | 86 | 2 | 12847218 | ||
| Pubmed | 1.26e-04 | 7 | 86 | 2 | 11867212 | ||
| Pubmed | 1.26e-04 | 7 | 86 | 2 | 7921537 | ||
| Pubmed | Impaired expression of Notch signaling genes in aged human skeletal muscle. | 1.26e-04 | 7 | 86 | 2 | 17301032 | |
| Pubmed | Premature aggregation of type IV collagen and early lethality in lysyl hydroxylase 3 null mice. | 1.26e-04 | 7 | 86 | 2 | 15377789 | |
| Pubmed | 1.26e-04 | 7 | 86 | 2 | 21151910 | ||
| Pubmed | 1.56e-04 | 42 | 86 | 3 | 23863479 | ||
| Pubmed | Extracellular-matrix gene expression during mouse submandibular gland development. | 1.68e-04 | 8 | 86 | 2 | 9382709 | |
| Interaction | VEGFA interactions | 9.16e-06 | 66 | 86 | 5 | int:VEGFA | |
| Cytoband | 19q13.43 | 2.27e-05 | 87 | 86 | 4 | 19q13.43 | |
| Cytoband | 15q25.1 | 1.98e-03 | 35 | 86 | 2 | 15q25.1 | |
| Cytoband | 7q22 | 2.33e-03 | 38 | 86 | 2 | 7q22 | |
| Cytoband | 12q12 | 3.55e-03 | 47 | 86 | 2 | 12q12 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF597 ZNF8 ZNF133 ZNF821 ZNF536 ZNF547 ZNF268 ZNF549 ZNF423 ZNF256 ZNF518B ZNF625 ZNF354B | 2.29e-06 | 718 | 68 | 13 | 28 |
| GeneFamily | LIM domain containing | 7.13e-05 | 59 | 68 | 4 | 1218 | |
| GeneFamily | Zinc fingers AN1-type|UPF1 like RNA helicases | 3.85e-04 | 8 | 68 | 2 | 63 | |
| GeneFamily | Laminin subunits | 8.98e-04 | 12 | 68 | 2 | 626 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 2.29e-03 | 19 | 68 | 2 | 50 | |
| GeneFamily | Solute carriers | 3.66e-03 | 395 | 68 | 6 | 752 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 9.72e-08 | 68 | 86 | 6 | M1373 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 1.37e-07 | 72 | 86 | 6 | MM1131 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.73e-07 | 196 | 86 | 8 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 3.07e-07 | 275 | 86 | 9 | M5884 | |
| Coexpression | NABA_MATRISOME | COL4A1 NELL2 MXRA5 FBLN2 FBN2 SCUBE2 IGFBP7 C1QL3 A2ML1 ADAMTS16 ADAMTS18 LAMC1 LAMC3 CCN2 ADAM8 | 1.13e-06 | 1026 | 86 | 15 | M5889 |
| Coexpression | WOOD_EBV_EBNA1_TARGETS_UP | 1.70e-06 | 110 | 86 | 6 | M1696 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 2.38e-06 | 352 | 86 | 9 | M17471 | |
| Coexpression | NABA_CORE_MATRISOME | 3.03e-06 | 270 | 86 | 8 | MM17057 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.23e-06 | 191 | 86 | 7 | MM17059 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 4.38e-06 | 200 | 86 | 7 | M5930 | |
| Coexpression | NABA_MATRISOME | COL4A1 NELL2 FBLN2 FBN2 SCUBE2 IGFBP7 C1QL3 A2ML1 ADAMTS16 ADAMTS18 LAMC1 LAMC3 CCN2 ADAM8 | 4.87e-06 | 1008 | 86 | 14 | MM17056 |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 4.92e-06 | 385 | 86 | 9 | M39264 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 5.60e-06 | 135 | 86 | 6 | M5825 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | COL4A1 MXRA5 IGFBP7 FZD5 ZNF423 LAMC1 CCN2 ADGRL2 CYP39A1 NOTCH3 EPHA3 NRP1 | 7.62e-06 | 767 | 86 | 12 | M39209 |
| Coexpression | PILON_KLF1_TARGETS_UP | COL4A1 GTF2IRD2B FBN2 IGFBP7 CLU FZD5 CIAPIN1 GTF2IRD2 ZFAND5 DLL1 | 1.12e-05 | 541 | 86 | 10 | MM1061 |
| Coexpression | ESC_V6.5_UP_EARLY.V1_DN | 1.64e-05 | 163 | 86 | 6 | M2769 | |
| Coexpression | SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP | 1.90e-05 | 99 | 86 | 5 | M3238 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 4.08e-05 | 503 | 86 | 9 | M2226 | |
| Coexpression | GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_DN | 4.38e-05 | 194 | 86 | 6 | M4683 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 4.38e-05 | 194 | 86 | 6 | M39122 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | ZNF536 FBLN2 SCUBE2 IGFBP7 FZD5 C1QL3 ADAMTS18 SLC13A5 LAMC3 CCN2 AJUBA KCNH3 EPHA3 | 4.63e-05 | 1074 | 86 | 13 | M1941 |
| Coexpression | GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_UP | 5.18e-05 | 200 | 86 | 6 | M7501 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP | TTBK2 ZNF133 PTPDC1 ZNF536 METTL25B IGFBP7 MIPEP CR1 AJUBA SLC29A1 SORD NRP1 | 5.74e-05 | 942 | 86 | 12 | M8144 |
| Coexpression | LI_CISPLATIN_RESISTANCE_UP | 8.40e-05 | 26 | 86 | 3 | M4717 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B | 8.56e-05 | 554 | 86 | 9 | M2244 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 9.42e-05 | 27 | 86 | 3 | M47994 | |
| Coexpression | KRAS.LUNG_UP.V1_UP | 9.96e-05 | 140 | 86 | 5 | M2897 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 1.58e-04 | 32 | 86 | 3 | M5903 | |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL | 2.09e-04 | 164 | 86 | 5 | M41676 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 2.56e-04 | 505 | 86 | 8 | M39167 | |
| Coexpression | CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP | 2.86e-04 | 39 | 86 | 3 | M13339 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | COL4A1 FBLN2 IGFBP7 CLU LAMC1 CCN2 DLL1 ADGRL2 NRP1 C16orf89 | 1.34e-05 | 459 | 84 | 10 | GSM777037_500 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 6.59e-05 | 445 | 84 | 9 | GSM777043_500 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 7.56e-05 | 453 | 84 | 9 | GSM777067_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 7.95e-05 | 456 | 84 | 9 | GSM777032_500 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.01e-08 | 180 | 86 | 7 | 64956a85c404a2ea7e4eaf6f95ebcc52c198b7cc | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.25e-08 | 185 | 86 | 7 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 7.80e-08 | 187 | 86 | 7 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.09e-08 | 188 | 86 | 7 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.34e-08 | 192 | 86 | 7 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.00e-07 | 194 | 86 | 7 | a7731378f44ca1a229311686caf5740c742d21ba | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.00e-07 | 194 | 86 | 7 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.07e-07 | 196 | 86 | 7 | 40e6900a0d56088a40d37ec312f53207ea952602 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.07e-07 | 196 | 86 | 7 | cb61757646653f89faba503cb5d99e5dd5197b4c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-07 | 196 | 86 | 7 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.07e-07 | 196 | 86 | 7 | cb5860f580b477bfa52b22cdc21b808e1371e6e0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.07e-07 | 196 | 86 | 7 | 73f029d2b276776d6c24356b14c6592c9cb74bd5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.07e-07 | 196 | 86 | 7 | 0b247cf981981ae61aca5de82ef687e8d783c9ef | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.07e-07 | 196 | 86 | 7 | 44e2df1b61e3819eae7e482bef0a733afe852d67 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.11e-07 | 197 | 86 | 7 | 1da8ba5bbab232add6e43ad78b15c2339d0c2bc3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.11e-07 | 197 | 86 | 7 | 12370ee857fddf1cf26196b23c21b68dcea48eb3 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.11e-07 | 197 | 86 | 7 | 236a40eb6c08e1d179cf0fb5450b032975c5f6b6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.11e-07 | 197 | 86 | 7 | af819b0561c8db582c5b466d804153d69d3297e0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.11e-07 | 197 | 86 | 7 | 983502a99e6d59bb36225b0246a9990604de1a01 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.15e-07 | 198 | 86 | 7 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-SCGB3A2+_SCGB1A1+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.15e-07 | 198 | 86 | 7 | a3d4b6e4259ded2193d94d2ff6d48cf67214fc35 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-07 | 198 | 86 | 7 | 75d104eead681f6bf47c4dd24913cc768c9a1717 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.15e-07 | 198 | 86 | 7 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-07 | 198 | 86 | 7 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | metastatic_Brain-Fibroblasts-FB-like_cells|metastatic_Brain / Location, Cell class and cell subclass | 1.19e-07 | 199 | 86 | 7 | 12133087eae9f0e9b6c13a71e8187117768e64ce | |
| ToppCell | metastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 1.19e-07 | 199 | 86 | 7 | 63eb2106bb6e2e33d020628583536c8d96662c84 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-07 | 199 | 86 | 7 | e78f661b40da34768469549b6e755d330be6bbd8 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-07 | 200 | 86 | 7 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-07 | 200 | 86 | 7 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.36e-07 | 158 | 86 | 6 | 32c95c1bc9e50fccd6d06e828f29258fc5e568cb | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.10e-07 | 161 | 86 | 6 | 82ed45f144a07856fe92d37426c5f92e259a03a9 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.42e-07 | 169 | 86 | 6 | 47fd4adfe54777e69a0fabf8bd34f26223f63275 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.42e-07 | 169 | 86 | 6 | e09259d62cd3e42f0919f231ed1164db59b0b6c3 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.36e-06 | 180 | 86 | 6 | 0b1d370db64862fe1c7ea0ffaf06d03ec82e6e70 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-06 | 181 | 86 | 6 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-06 | 181 | 86 | 6 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.45e-06 | 182 | 86 | 6 | 997d37ca2af661c92a56add888762724dfccc890 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.45e-06 | 182 | 86 | 6 | fc4a5bf784705efe7965ce43ac23c2a8e602e90a | |
| ToppCell | COPD-Endothelial-VE_Venous|COPD / Disease state, Lineage and Cell class | 1.55e-06 | 184 | 86 | 6 | 44d716e7ba46a1ed03f5992631289653f8fd7d5e | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 1.59e-06 | 185 | 86 | 6 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.65e-06 | 186 | 86 | 6 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | Control-Fibroblasts-Pathological_FB|Control / group, cell type (main and fine annotations) | 1.70e-06 | 187 | 86 | 6 | b7280b8baa0fba9c2b4bff660c240ed96f6ff9b7 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.70e-06 | 187 | 86 | 6 | 6820bfbe552ea5e62cfe699687b051a17d9fda61 | |
| ToppCell | 15-Trachea-Epithelial-Secretory_progenitor|Trachea / Age, Tissue, Lineage and Cell class | 1.70e-06 | 187 | 86 | 6 | be9fce9e74b2f170a2067f1b31d802912a578329 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.75e-06 | 188 | 86 | 6 | a906c29e3fda22eecfec3e5cac706c417bf2b7a4 | |
| ToppCell | Endothelial-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.81e-06 | 189 | 86 | 6 | 04b565855f58ca0f343904d04be657b66e109076 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-06 | 190 | 86 | 6 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-06 | 190 | 86 | 6 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.86e-06 | 190 | 86 | 6 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-06 | 190 | 86 | 6 | c1bfc1960a3df49c0f459454a7363804c32418ee | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-06 | 191 | 86 | 6 | 5c1f5b6c115b1b27b4a7467a6550ce43c01cf6d0 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-06 | 191 | 86 | 6 | 1924af7d8b0a0b892e480a9fd6d874941b0c0b5d | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-06 | 191 | 86 | 6 | 88f91e57a1409bdeb91e9bf47510a6fb998a1bf5 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.92e-06 | 191 | 86 | 6 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-06 | 192 | 86 | 6 | 53d438e35c14e7656585942b788459e6d843c555 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.98e-06 | 192 | 86 | 6 | 09cb5b89a164ac7444774ccc8c90323c8ea2026b | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-06 | 192 | 86 | 6 | 9a1aeac3ecf31f865a23d8ee15a82aef31779089 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 192 | 86 | 6 | eb9a0b3d32f90f8b95905c740aab21639dae5cbd | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 192 | 86 | 6 | f094ac378e635cf5820e8a8b7a0152073a51ceae | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-06 | 193 | 86 | 6 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.04e-06 | 193 | 86 | 6 | dd4bac8a93a5b9dcf7301f1d7d6e3eb6670f5c68 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-06 | 193 | 86 | 6 | a9349ed5f3c34dcf817b3e84737e5946922ddff3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.04e-06 | 193 | 86 | 6 | 2ddf9b2770a0be9689e01d1a3d19e4a6d42c7a50 | |
| ToppCell | IPF-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 2.04e-06 | 193 | 86 | 6 | ef66a46e7ab44fcc4005a23416e6da478a4cce37 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.10e-06 | 194 | 86 | 6 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.10e-06 | 194 | 86 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.16e-06 | 195 | 86 | 6 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-06 | 195 | 86 | 6 | 12ba6d95e42d06b1991b011043c0e3370a7b4131 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.16e-06 | 195 | 86 | 6 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.16e-06 | 195 | 86 | 6 | d760d1423f9a8a373fe7b250ea9b1d67a0c0059f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.23e-06 | 196 | 86 | 6 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.23e-06 | 196 | 86 | 6 | 9a420a4eb46cb554bec641726fea5398ff60f630 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.23e-06 | 196 | 86 | 6 | 5609b2d93172a488b35d854298a3a4e504e17e28 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.23e-06 | 196 | 86 | 6 | 7acd782a587b7d331517f60daa8b5c2177bedfc7 | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 2.23e-06 | 196 | 86 | 6 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-06 | 197 | 86 | 6 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.29e-06 | 197 | 86 | 6 | 2e3d64648a1e4f01b9256a96b94b8a640ee1824c | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.29e-06 | 197 | 86 | 6 | f969685dee212f33a6f09e54c0cd1fd24ffef546 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-06 | 197 | 86 | 6 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.29e-06 | 197 | 86 | 6 | 1a137af40697137bb9d2b5caf2b1ffda55f04461 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.29e-06 | 197 | 86 | 6 | 69fde2d27881f8408216e231c71cfdbd96f28d45 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.29e-06 | 197 | 86 | 6 | 4a04da876a1482604452ae53c124ae68eda0bd5e | |
| ToppCell | COPD-Stromal|COPD / Disease state, Lineage and Cell class | 2.29e-06 | 197 | 86 | 6 | d5390d86acaa8c39f1da893e8d2271f9ed2951d7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.29e-06 | 197 | 86 | 6 | 2872a78b1be61aa1d50bc9a49294a21e922dc033 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.29e-06 | 197 | 86 | 6 | 96d63a8d00583e2aa0a38412e2ae27e23f399493 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.36e-06 | 198 | 86 | 6 | d83707b69fb64721ac3cff90ba58cdd999d6b386 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-06 | 198 | 86 | 6 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | IPF-Stromal|IPF / Disease state, Lineage and Cell class | 2.36e-06 | 198 | 86 | 6 | ece914c32c9b123b779aa9624b92e6230763a20e | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.43e-06 | 199 | 86 | 6 | ec74ff85d6b61013b1f785b2fca343759feb7843 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.43e-06 | 199 | 86 | 6 | aacd3ffa40a6e6f435aa9be5b959d88812eb69d4 | |
| ToppCell | ILEUM-inflamed-(8)_Activated_fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.43e-06 | 199 | 86 | 6 | 317f412996d463ddf2e6a52ff41d5d676c77f43f | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.43e-06 | 199 | 86 | 6 | 1c69395c9305b6ecb0a826d46c8e8ec95795ad6d | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.43e-06 | 199 | 86 | 6 | 6139687a3a5025cb98da4dba0183f95fcae3dc61 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.43e-06 | 199 | 86 | 6 | 6fb81388c5045e81c3849a7136bdff3f953f044e | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.43e-06 | 199 | 86 | 6 | 6a0df9a2f30480043f9c1d7fbdede17eb0910cac | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.50e-06 | 200 | 86 | 6 | be527df943a8cedc6452ecef3cafc282db34ceb8 | |
| ToppCell | Biopsy_Other_PF-Endothelial|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.50e-06 | 200 | 86 | 6 | f9916134486fb1dac55f5e7e8deb35e7a3b85770 | |
| ToppCell | COVID-19-Fibroblasts-Pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.50e-06 | 200 | 86 | 6 | 73e01b7bc43320a991c67a4fd0c04708f893c7ea | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.50e-06 | 200 | 86 | 6 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.50e-06 | 200 | 86 | 6 | 4e1e19214aeebbdca004de7faaf4cc9d18498591 | |
| Disease | Impaired cognition | 5.98e-08 | 14 | 84 | 4 | C0338656 | |
| Disease | respiratory symptom measurement, COVID-19 | 2.29e-06 | 74 | 84 | 5 | EFO_0007939, MONDO_0100096 | |
| Disease | anemia (implicated_via_orthology) | 9.88e-06 | 15 | 84 | 3 | DOID:2355 (implicated_via_orthology) | |
| Disease | corpus callosum volume measurement | 1.01e-05 | 100 | 84 | 5 | EFO_0010299 | |
| Disease | Alzheimer disease, fasting blood insulin measurement | 4.79e-05 | 4 | 84 | 2 | EFO_0004466, MONDO_0004975 | |
| Disease | urinary potassium to creatinine ratio | 1.19e-04 | 6 | 84 | 2 | EFO_0009882 | |
| Disease | X-24494 measurement | 1.67e-04 | 7 | 84 | 2 | EFO_0800889 | |
| Disease | Walker-Warburg syndrome (implicated_via_orthology) | 1.67e-04 | 7 | 84 | 2 | DOID:0050560 (implicated_via_orthology) | |
| Disease | Pancreatic Neoplasm | 1.95e-04 | 100 | 84 | 4 | C0030297 | |
| Disease | multiple system atrophy | 2.04e-04 | 40 | 84 | 3 | EFO_1001050 | |
| Disease | Malignant neoplasm of pancreas | 2.10e-04 | 102 | 84 | 4 | C0346647 | |
| Disease | Mental deterioration | 2.85e-04 | 9 | 84 | 2 | C0234985 | |
| Disease | Mild cognitive disorder | 2.85e-04 | 9 | 84 | 2 | C1270972 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 40 | 2.85e-04 | 9 | 84 | 2 | C4225275 | |
| Disease | phenylacetate measurement | 5.19e-04 | 12 | 84 | 2 | EFO_0021012 | |
| Disease | 11beta-hydroxyandrosterone glucuronide measurement | 5.19e-04 | 12 | 84 | 2 | EFO_0800573 | |
| Disease | X-11444 measurement | 6.12e-04 | 13 | 84 | 2 | EFO_0021237 | |
| Disease | Migraine Disorders | 6.12e-04 | 13 | 84 | 2 | C0149931 | |
| Disease | amino acid measurement | 7.01e-04 | 678 | 84 | 8 | EFO_0005134 | |
| Disease | Alzheimer disease, educational attainment | 7.11e-04 | 247 | 84 | 5 | EFO_0011015, MONDO_0004975 | |
| Disease | Walker-Warburg congenital muscular dystrophy | 8.21e-04 | 15 | 84 | 2 | C0265221 | |
| Disease | Colorectal Carcinoma | 8.77e-04 | 702 | 84 | 8 | C0009402 | |
| Disease | diabetic nephropathy | 9.03e-04 | 150 | 84 | 4 | EFO_0000401 | |
| Disease | Dementia | 1.06e-03 | 17 | 84 | 2 | C0497327 | |
| Disease | renal fibrosis (implicated_via_orthology) | 1.06e-03 | 17 | 84 | 2 | DOID:0050855 (implicated_via_orthology) | |
| Disease | parahippocampal gyrus volume measurement | 1.19e-03 | 18 | 84 | 2 | EFO_0010318 | |
| Disease | epilepsy (implicated_via_orthology) | 1.23e-03 | 163 | 84 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | etiocholanolone glucuronide measurement | 1.33e-03 | 19 | 84 | 2 | EFO_0800362 | |
| Disease | cortical surface area measurement | ZNF536 FBN2 ZNF423 SLC4A10 ADAMTS18 LAMC1 LAMC3 ADGRL2 AJUBA EPHA3 NRP1 | 1.49e-03 | 1345 | 84 | 11 | EFO_0010736 |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 1.56e-03 | 80 | 84 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | treatment resistant depression, response to antidepressant | 1.62e-03 | 21 | 84 | 2 | EFO_0009854, GO_0036276 | |
| Disease | cardiovascular system disease (is_implicated_in) | 1.62e-03 | 21 | 84 | 2 | DOID:1287 (is_implicated_in) | |
| Disease | Prostatic Neoplasms | 1.89e-03 | 616 | 84 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.89e-03 | 616 | 84 | 7 | C0376358 | |
| Disease | Carcinoma of lung | 1.95e-03 | 23 | 84 | 2 | C0684249 | |
| Disease | temperament and character inventory | 2.12e-03 | 24 | 84 | 2 | EFO_0004825 | |
| Disease | Postural instability | 2.30e-03 | 25 | 84 | 2 | HP_0002172 | |
| Disease | waist-hip ratio | PRMT6 COL4A1 GIPR PTPDC1 SCUBE2 ZNF268 ZNF423 ABHD17C EPHA3 NRP1 | 2.51e-03 | 1226 | 84 | 10 | EFO_0004343 |
| Disease | Encephalopathies | 2.68e-03 | 27 | 84 | 2 | C0085584 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FACLSSKYMCPGVPA | 881 | Q9UPW8 | |
| FCYCRKLGTAMNPCS | 116 | O00253 | |
| DLCRSLMTKPGCSGY | 181 | Q6UX73 | |
| LMTKPGCSGYCLSHQ | 186 | Q6UX73 | |
| GLFFLCGSSTYMCLP | 336 | Q9N2K0 | |
| GLFFLCGSSTYMCLP | 336 | Q9N2J8 | |
| FCMTGGNSPICYLKA | 151 | Q9BXI3 | |
| QAMGKSYHPGCFRCI | 416 | Q96IF1 | |
| GGFCTPRYMSCLRDA | 36 | O43306 | |
| GTCRMVCDPYGGTKA | 26 | Q5VWW1 | |
| CCRYTYGKPMLGAVQ | 241 | A8K2U0 | |
| PRYVTGACCLFLAGK | 91 | O75909 | |
| DAFRCASCPYLGMPA | 281 | Q6FI81 | |
| PCPKGTRGTASYLCM | 491 | O95490 | |
| PSGLACNGSFDMYVC | 56 | P48546 | |
| LPGCKASRYRADMCG | 536 | P78325 | |
| CKMGRYNLSPSIFFC | 106 | Q00796 | |
| TLGFAPISGMCSKYR | 401 | Q8TE57 | |
| GFAPISGMCSKYRSC | 406 | Q8TE60 | |
| GSCLRKFSTMPFLFC | 1491 | P02462 | |
| LPLCYFSSKCMCSSG | 201 | Q5RL73 | |
| MQRGCACSFLYGPDT | 61 | Q9ULD8 | |
| PGSFMCICKTGYIRI | 461 | Q99435 | |
| CDMVYKLPFGSSCTG | 1901 | Q9UPA5 | |
| ICSCFPGYAIMADGV | 701 | P98095 | |
| RTCRMCFYGTGLIAG | 461 | Q5XUX0 | |
| DRVASFYCACPMGKT | 331 | Q9UM47 | |
| AIGYMCCPFVLDKDG | 426 | Q96G03 | |
| DFLAMFSPKCGGCNR | 261 | O60711 | |
| ASVGCCYMKLSDPGG | 281 | Q96FB5 | |
| GVKETSMPVYCSCAG | 2226 | Q07864 | |
| MACGGRACKYENPAR | 56 | A2A3K4 | |
| AGRGYCAPGMECVKS | 76 | Q16270 | |
| ACMTYFPRACGSLKG | 201 | Q8IZL8 | |
| VYGCKITDYPCSGML | 421 | O14786 | |
| ACSCAVGIKYMGVFT | 196 | Q9Y6A1 | |
| GGQRYIMKDGRPFCC | 226 | Q96MT3 | |
| FRGLEICCYGPFTNM | 1761 | P38398 | |
| RAKAGCSPLMRQYGF | 111 | Q13467 | |
| CRPGYFGKMFSISCL | 1426 | P17927 | |
| PGFYGKICELSAMTC | 356 | O00548 | |
| MKTYRAKFCGVCTDG | 276 | P29279 | |
| GCMFVRCAPSSRYTL | 121 | Q6PCB6 | |
| VGGRFRCSCYGSAPM | 271 | Q96LA8 | |
| RCSCYGSAPMHGFAI | 276 | Q96LA8 | |
| RGFMCQACRPGFYKA | 266 | P29320 | |
| DSYGRCSCKPGVMGD | 411 | P11047 | |
| KCYLMPFGTGTSKCP | 436 | O75881 | |
| YLVGFCPEGPSCKFM | 151 | O95639 | |
| LDCFMAFGSGKFQCP | 401 | Q9NYL5 | |
| PGMCTYGKCRNTIGS | 1081 | P35556 | |
| CFCYGKALGTTVMVP | 116 | Q86UP8 | |
| CFCYGKALGTTVMVP | 116 | Q6EKJ0 | |
| KAMTLCICYAASIGG | 206 | Q86YT5 | |
| PGNYRCTCFDGFMLA | 106 | Q9NQ36 | |
| KVLRFCACAGMIYLG | 416 | Q8IZK6 | |
| FAANYCRSGKGPILM | 266 | P29803 | |
| YCACMSPVITFGGLL | 616 | Q9Y6M7 | |
| FSEGACKPGYASALM | 81 | Q11203 | |
| YCACMSPVITFGGLL | 486 | Q2Y0W8 | |
| SNGYLASLCMCFGPK | 406 | Q99808 | |
| SPVCGSDGLMYFSLC | 516 | Q96BD0 | |
| SDGLMYFSLCHAGCP | 521 | Q96BD0 | |
| CMKFYARVCRSGSGL | 121 | P10909 | |
| LRAMGKAYHPGCFTC | 351 | Q15654 | |
| TGERPYVCMECGKSF | 356 | Q6P9A3 | |
| YGNPRTNGMCSVCYK | 21 | O76080 | |
| GMKPYVCNECGKAFR | 496 | Q14587 | |
| LYCPFFSLGACMEGL | 376 | Q99797 | |
| LCGMGNFKRETVYGC | 311 | Q0ZLH3 | |
| YGNPRTNGMCSVCYK | 21 | Q6FIF0 | |
| TGMRPYECSECGKSF | 346 | Q9Y2P7 | |
| LYCACMSPVITFGGL | 516 | Q6U841 | |
| NFAMGRFPSTCRKCY | 146 | Q6IQ55 | |
| RFPSTCRKCYMLDFG | 151 | Q6IQ55 | |
| GGCGACTVMLSKYDR | 46 | P47989 | |
| YSAVRPFGCSFMLGS | 126 | P25788 | |
| RMTLCAGICSYEGKG | 71 | Q9H040 | |
| LGSAMKDCPYCGKTF | 746 | O15090 | |
| KPYMCSECGRGFSQK | 296 | P52736 | |
| REKPYMCRQCGLGFG | 546 | P52736 | |
| GERPYECSECGKLFM | 236 | Q8IVP9 | |
| GERPYMCKECGKAFS | 281 | P17098 | |
| SAKSYMCPVCGRALS | 146 | O75541 | |
| RIMHSGDGPYKCNFC | 116 | Q96I27 | |
| GDGPYKCNFCGKALM | 121 | Q96I27 | |
| KEKPYTCSICGRGFM | 236 | Q96LX8 | |
| MGFCAPKKIPSFCYS | 146 | P48307 | |
| GLPYGLCAGCMARSA | 1086 | Q2M1K9 | |
| PYRCLECGMSFGQSA | 521 | Q96LW1 | |
| SMPRGANTFCYCVKA | 321 | B1ANS9 | |
| DGMYVCFQCSLGAAP | 81 | Q9C0D4 | |
| GQFCESCAPGYKREM | 681 | Q9Y6N6 | |
| AYEGGQLCAMCFSPK | 246 | Q9NR99 |